Promises and limitations of immune cell-based therapies in neurological disorders

[1]  R. Alon,et al.  CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. , 2014, The Journal of clinical investigation.

[2]  R. Kumar,et al.  Update on Dendritic Cell-Induced Immunological and Clinical Tolerance , 2017, Front. Immunol..

[3]  A. Vandenbark,et al.  Sex differences in regulatory cells in experimental stroke. , 2017, Cellular immunology.

[4]  Giovanna Lombardi,et al.  Treg therapy in transplantation: a general overview , 2017, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  Simon C Watkins,et al.  C‐C Chemokine Receptor Type 5 (CCR5)‐Mediated Docking of Transferred Tregs Protects Against Early Blood‐Brain Barrier Disruption After Stroke , 2017, Journal of the American Heart Association.

[6]  Weifeng Yu,et al.  Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke , 2017, Brain : a journal of neurology.

[7]  W. Qian,et al.  Changes in Regulatory T-Cell Levels in Acute Cerebral Ischemia , 2017, Journal of Neurological Surgery Part A: Central European Neurosurgery.

[8]  P. Hamilton,et al.  Regulatory T cells promote myelin regeneration in the Central Nervous System , 2017, Nature Neuroscience.

[9]  E. Shpall,et al.  ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. , 2017, JCI insight.

[10]  Qing-Wu Yang,et al.  Regulatory T cells ameliorate intracerebral hemorrhage-induced inflammatory injury by modulating microglia/macrophage polarization through the IL-10/GSK3β/PTEN axis , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  D. Scott,et al.  FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII. , 2017, Blood.

[12]  Ming-feng Yang,et al.  Adoptive Regulatory T-cell Therapy Attenuates Perihematomal Inflammation in a Mouse Model of Experimental Intracerebral Hemorrhage , 2017, Cellular and Molecular Neurobiology.

[13]  Jiusheng Deng,et al.  Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation , 2016, The Journal of Neuroscience.

[14]  R. Başar,et al.  A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. , 2016, Cytotherapy.

[15]  G. D. de Freitas,et al.  Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage , 2016, Stem cells international.

[16]  H. Okada,et al.  Cellular immunotherapy for malignant gliomas , 2016, Expert opinion on biological therapy.

[17]  M. Dichgans,et al.  Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke , 2016, The Journal of Neuroscience.

[18]  P. Fallon,et al.  Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells , 2016, Nature Communications.

[19]  Y. Wang,et al.  Adoptive Regulatory T-cell Therapy Attenuates Subarachnoid Hemor-rhage-induced Cerebral Inflammation by Suppressing TLR4/NF-B Signaling Pathway. , 2016, Current neurovascular research.

[20]  Nicolas Cagnard,et al.  REGULATORY T CELLS DELAY DISEASE PROGRESSION IN ALZHEIMER’S-LIKE PATHOLOGY , 2016, Alzheimer's & Dementia.

[21]  M. Levings,et al.  Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. , 2016, The Journal of clinical investigation.

[22]  Y. Mao-Draayer,et al.  Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[23]  Eric G. Pamer,et al.  Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδT cells , 2016, Nature Medicine.

[24]  A. Moore,et al.  Expanding antigen-specific regulatory networks to treat autoimmunity , 2016, Nature.

[25]  T. Mak,et al.  CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity , 2016, Proceedings of the National Academy of Sciences.

[26]  M. Levings,et al.  Discarded Human Thymus Is a Novel Source of Stable and Long‐Lived Therapeutic Regulatory T Cells , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  S. Bykovskaia,et al.  [The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis]. , 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[28]  Yan-wen Shu,et al.  Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1. , 2016, Atherosclerosis.

[29]  Jeffrey A. Bluestone,et al.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells , 2015, Science Translational Medicine.

[30]  P. Mccombe,et al.  Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome , 2015, Journal of Neuroimmunology.

[31]  Ji-xian Wang,et al.  Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10 , 2015, Front. Cell. Neurosci..

[32]  F. Shi,et al.  Immune interventions in stroke , 2015, Nature Reviews Neurology.

[33]  M. Schwartz,et al.  Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology , 2015, Nature Communications.

[34]  R. Negrin,et al.  Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease. , 2015, Blood.

[35]  Ahmed M. Mehdi,et al.  Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients , 2015, Science Translational Medicine.

[36]  G. Rogers,et al.  Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg. , 2015, Blood.

[37]  R. Wiseman,et al.  Sequential Monitoring and Stability of Ex Vivo–Expanded Autologous and Nonautologous Regulatory T Cells Following Infusion in Nonhuman Primates , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[39]  E. Bonifacio,et al.  Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. , 2015, Cytotherapy.

[40]  A. Sharma,et al.  A Clinical Study of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Patients: A New Frontier , 2015, Stem cells international.

[41]  R. Leak,et al.  Microglial and macrophage polarization—new prospects for brain repair , 2015, Nature Reviews Neurology.

[42]  A. Vandenbark,et al.  Regulatory CD8+CD122+ T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells , 2014, Metabolic Brain Disease.

[43]  Roberto A. Maldonado,et al.  Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance , 2014, Proceedings of the National Academy of Sciences.

[44]  K. Berer,et al.  Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS , 2014, Acta neuropathologica communications.

[45]  Simon A. Jones,et al.  Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.

[46]  W. Kuo,et al.  NAD+ protects against EAE by regulating CD4+ T-cell differentiation , 2014, Nature Communications.

[47]  A. Thomson,et al.  Regulatory dendritic cell therapy: from rodents to clinical application. , 2014, Immunology letters.

[48]  S. Grupp,et al.  Current concepts in the diagnosis and management of cytokine release syndrome. , 2014, Blood.

[49]  J. Konkel,et al.  In Vivo–Generated Antigen-Specific Regulatory T Cells Treat Autoimmunity Without Compromising Antibacterial Immune Response , 2014, Science Translational Medicine.

[50]  Siok-Keen Tey.  Adoptive T-cell therapy: adverse events and safety switches , 2014, Clinical & translational immunology.

[51]  J. Markmann,et al.  TGF‐β‐producing regulatory B cells induce regulatory T cells and promote transplantation tolerance , 2014, European journal of immunology.

[52]  F. Campos,et al.  Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia , 2014, Journal of cellular and molecular medicine.

[53]  R. Alon,et al.  CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. , 2014, The Journal of clinical investigation.

[54]  M. Boninger,et al.  Identification of distinct monocyte phenotypes and correlation with circulating cytokine profiles in acute response to spinal cord injury: a pilot study. , 2014, PM & R : the journal of injury, function, and rehabilitation.

[55]  B. Levine,et al.  Adoptive immunotherapy for cancer or viruses. , 2014, Annual review of immunology.

[56]  Amit Bar-Or,et al.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases , 2014, Nature.

[57]  P. Sawchenko,et al.  Immune cell trafficking from the brain maintains CNS immune tolerance. , 2014, The Journal of clinical investigation.

[58]  Jun Chen,et al.  Essential Role of Program Death 1-Ligand 1 in Regulatory T-Cell–Afforded Protection Against Blood–Brain Barrier Damage After Stroke , 2014, Stroke.

[59]  R. Banerjee,et al.  Aging is associated with increased regulatory T-cell function , 2014, Aging cell.

[60]  A. Vandenbark,et al.  Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice , 2013, Metabolic Brain Disease.

[61]  R. Leak,et al.  Adoptive Regulatory T-Cell Therapy Preserves Systemic Immune Homeostasis After Cerebral Ischemia , 2013, Stroke.

[62]  Kenji Kamiyama,et al.  The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[63]  Tracy J. Yuen,et al.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination , 2013, Nature Neuroscience.

[64]  F. Zhang,et al.  Adoptive regulatory T‐cell therapy protects against cerebral ischemia , 2013, Annals of neurology.

[65]  A. Vandenbark,et al.  IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke , 2013, Metabolic Brain Disease.

[66]  R. Kreienberg,et al.  Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. , 2013, Cancer research.

[67]  P. Jakob,et al.  Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. , 2013, Blood.

[68]  S. Powell,et al.  Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival , 2012, EMBO molecular medicine.

[69]  E. Shevach.  Application of IL-2 therapy to target T regulatory cell function. , 2012, Trends in immunology.

[70]  S. Appel,et al.  Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms , 2012, Neurobiology of Disease.

[71]  Aaron J. Martin,et al.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis , 2012, Nature Biotechnology.

[72]  R. Bhatia,et al.  Autologous Intravenous Mononuclear Stem Cell Therapy in Chronic Ischemic Stroke , 2012, Journal of stem cells & regenerative medicine.

[73]  C. Gerloff,et al.  Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. , 2012, Blood.

[74]  R. Leak,et al.  Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia , 2012, Stroke.

[75]  G. Azizi,et al.  The Role of Different Subsets of Regulatory T Cells in Immunopathogenesis of Rheumatoid Arthritis , 2012, Arthritis.

[76]  Kosloski,et al.  CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease , 2012, Journal of Neuroimmune Pharmacology.

[77]  N. Alkayed,et al.  Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice , 2012, Metabolic Brain Disease.

[78]  N. Salzman,et al.  A Novel IL-10–Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand , 2012, The Journal of Immunology.

[79]  F. Borràs,et al.  Stable antigen‐specific T‐cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients , 2012, European journal of immunology.

[80]  J. O'Sullivan,et al.  Frequency and function of regulatory T cells after ischaemic stroke in humans , 2012, Journal of Neuroimmunology.

[81]  Herman Waldmann,et al.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. , 2012, Immunity.

[82]  M. Roncarolo,et al.  Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID. , 2012, Blood.

[83]  G. Pawelec,et al.  Immune profiling of Alzheimer patients , 2012, Journal of Neuroimmunology.

[84]  M. Essand,et al.  CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery , 2012, Journal of Neuroinflammation.

[85]  Adrian P Gee,et al.  Inducible apoptosis as a safety switch for adoptive cell therapy. , 2011, The New England journal of medicine.

[86]  James T. Walsh,et al.  Regulatory T cells in CNS injury: the simple, the complex and the confused. , 2011, Trends in molecular medicine.

[87]  P. Hurn,et al.  Regulatory B Cells Limit CNS Inflammation and Neurologic Deficits in Murine Experimental Stroke , 2011, The Journal of Neuroscience.

[88]  G. Hu,et al.  Novel role of aquaporin‐4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson’s disease , 2011, Aging cell.

[89]  Y. Baba,et al.  The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. , 2011, Immunity.

[90]  B. Malissen,et al.  Integrated T‐cell receptor and costimulatory signals determine TGF‐β‐dependent differentiation and maintenance of Foxp3+ regulatory T cells , 2011, European journal of immunology.

[91]  D. Glotz,et al.  Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions , 2011, Proceedings of the National Academy of Sciences.

[92]  J. Wagner,et al.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.

[93]  J. Michálek,et al.  Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis , 2011, Journal of the Neurological Sciences.

[94]  E. S. St. Clair,et al.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.

[95]  W. Reith,et al.  MHC class II–restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell–mediated autoimmunity , 2010, The Journal of experimental medicine.

[96]  H. Okamura,et al.  Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke , 2010, Journal of neuroscience research.

[97]  T. Tedder,et al.  Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis , 2010, The Journal of Immunology.

[98]  H. Dai,et al.  Cutting Edge: Programmed Death-1 Defines CD8+CD122+ T Cells as Regulatory versus Memory T Cells , 2010, The Journal of Immunology.

[99]  A. Enk,et al.  Endothelial Cells Augment the Suppressive Function of CD4+CD25+Foxp3+ Regulatory T Cells: Involvement of Programmed Death-1 and IL-10 , 2010, The Journal of Immunology.

[100]  H. Wiendl,et al.  Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. , 2010, Blood.

[101]  H. Gendelman,et al.  Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease , 2010, The Journal of Immunology.

[102]  D. Isenberg,et al.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. , 2010, Immunity.

[103]  Arachimani Anand Kumar,et al.  Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. , 2009, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[104]  Gisen Kim,et al.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.

[105]  J. Myśliwska,et al.  First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. , 2009, Clinical immunology.

[106]  T. Iwaki,et al.  Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury , 2009, Nature Medicine.

[107]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[108]  James L Riley,et al.  Human T regulatory cell therapy: take a billion or so and call me in the morning. , 2009, Immunity.

[109]  S. Kaveri,et al.  Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. , 2009, The American journal of pathology.

[110]  D. Voehringer,et al.  Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity , 2009, The Journal of experimental medicine.

[111]  B. Malissen,et al.  Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity , 2009, Proceedings of the National Academy of Sciences.

[112]  C. Sommer,et al.  Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke , 2009, Nature Medicine.

[113]  J. Pandian,et al.  Immune activation in the peripheral blood of patients with acute ischemic stroke , 2009, Journal of Neuroimmunology.

[114]  Eugenio Gutiérrez-Jiménez,et al.  Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. , 2009, Cytotherapy.

[115]  Amit Awasthi,et al.  IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells , 2008, Proceedings of the National Academy of Sciences.

[116]  G. Hämmerling,et al.  Mitomycin C-treated dendritic cells inactivate autoreactive T cells: Toward the development of a tolerogenic vaccine in autoimmune diseases , 2008, Proceedings of the National Academy of Sciences.

[117]  David C. Gondek,et al.  Transplantation Survival Is Maintained by Granzyme B+ Regulatory Cells and Adaptive Regulatory T Cells , 2008, The Journal of Immunology.

[118]  J. Wagner,et al.  Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. , 2008, Blood.

[119]  M. Fujimoto,et al.  Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. , 2008, The Journal of clinical investigation.

[120]  S. Miller,et al.  Cutting Edge: Central Nervous System Plasmacytoid Dendritic Cells Regulate the Severity of Relapsing Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.

[121]  H. Gendelman,et al.  Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease , 2007 .

[122]  L. Stoltze,et al.  Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration , 2007, Journal of Neuroimmunology.

[123]  R. Lechler,et al.  Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. , 2007, Blood.

[124]  R. Lechler,et al.  In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. , 2007, Blood.

[125]  Loise M. Francisco,et al.  Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo1 , 2006, The Journal of Immunology.

[126]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[127]  J. Blay,et al.  CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner , 2005, The Journal of experimental medicine.

[128]  L. A. Stephens,et al.  Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.

[129]  S. Ziegler,et al.  Decreased FOXP3 levels in multiple sclerosis patients , 2005, Journal of neuroscience research.

[130]  Rohit Divekar,et al.  Specific T Regulatory Cells Display Broad Suppressive Functions against Experimental Allergic Encephalomyelitis upon Activation with Cognate Antigen1 , 2005, The Journal of Immunology.

[131]  S. Senju,et al.  Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand1 , 2005, The Journal of Immunology.

[132]  C. Drake,et al.  Role of LAG-3 in regulatory T cells. , 2004, Immunity.

[133]  T. Ley,et al.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death. , 2004, Immunity.

[134]  Shimon Sakaguchi,et al.  IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. , 2004, International immunology.

[135]  S. Miller,et al.  EncephalomyelitisExperimental Autoimmune System Inflammation During Active Immune Responses and Central Nervous Cells Suppress Antigen-Specific Autoreactive Regulatory T + CD25+ Cutting Edge: CD4 , 2022 .

[136]  A. Coutinho,et al.  Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[137]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[138]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[139]  P. Kivisäkk,et al.  High levels of IL‐10 secreting cells are present in blood in cerebrovascular diseases , 1999, European journal of neurology.

[140]  M. P. Smith,et al.  The New Frontier. , 1984, RNABC news.

[141]  R J Donaldson,et al.  A General Overview , 1980, Royal Society of Health journal.